ESCMID Study Group for Clostridioides difficile - ESGCD

ESGCD Annual Report

Download the latest Annual Report.

News & Activities


ESGCD Websymposium: Beyond Faecal microbiota transplantation (FMT)

Two of the study groups from ESCMID, ESGCD (C. diff) and ESGHMI (Host and microbiota interaction) are planning a joint webinar entitled 'Beyond FMT'; covering potential aspects such as microbiota defined therapies. The webinar will be on the 12th October at 4pm CEST. We hope that you are able to join us for what is sure to be a fascinating look at new options for treating and preventing C. difficile.

 

Our speakers will be: Vincent B. Young, M.D., Ph.D. William Henry Fitzbutler Collegiate Professor, Internal Medicine/Division of Infectious Diseases

 

Professor, Microbiology & Immunology. University of Michigan medical School and Gianluca Ianiro, MD, PhD, Digestive Disease Center, Fondazione Policlinico Universitario Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

 

Please use the link to join the meeting (no prior registration needed)

 

Join Meeting

 

ESGCD Websymposium: C. difficile typing: from bench to bedside

ESGCD will be hosting a websymposium on Wednesday, 30 March 2022 at 17:00 CEST.

Programme:
Chairs: Dr. Kerrie Davies, Prof. Fidelma Fitzpatrick

Typing using RBT/MLVA – Dr. Marcella Krutova
WGS as typing method – Dr. Sandra Janezic
IPC using typing – Prof. Frederic Barbut

Please use the link to join the meeting (no prior registration needed)

Join Meeting

2021 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2021 as well as what they plan for the future.

ESGCD introduction feat. Fidelma Fitzpatrick


New ESCMID/ESGCD guidance on the treatment for Clostridioides difficile infection in adults

In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first treatment guidance document for Clostridioides difficile infection (CDI). The growing literature on CDI antimicrobial treatment and novel treatment approaches, such as faecal microbiota transplantation (FMT) and toxin-binding monoclonal antibodies, prompted the ESCMID study group on C. difficile (ESGCD) to update the 2014 treatment guidance document for CDI in adults.

 

Now the ESCMID: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults as just been published and now available here.

ESGCD Newsletter, Winter 2021

The ESGCD Newsletter for Winter 2021 has just been published. Inside, the ESGCD Executive Committee describe the latest developments in Webinars, ECCMID highlights, publications and networking. You can download the full newsletter here

ESGCD Websymposium: Treatment and management of severe CDI

ESGCD will be hosting a websymposium on Wednesday, 1 December 2021 at 17:00 CET.

Chairpersons: Dr. Kerrie Davies and Prof. Fidelma Fitzpatrick
Speakers: Dr Aaron Doherty, Dr Conor Mulrooney and Dr Joffrey Van Prehn
Expert Speakers: Prof. Mark Wilcox and Prof. Deborah McNamara
 

Please use the link to join the meeting (no prior registration needed)

Join Meeting

ESGCD Promotional Video

ESGCD Newsletter Spring/Summer 2021

The ESGCD Newsletter for Spring and Summer 2021 has just been published. Inside, the ESGCD Executive Committee describe the latest developments in research projects, educational activities and publications. You can download the full newsletter here

ESGCD Websymposium on recurrent CDI

Save the date! ESGCD will be hosting a websymposium on recurrent CDI on 27th April at 17:00 CEST. The websymposium will include the presentation of two clinical cases and an expert discussion, led by Prof Ed Kuijper and Prof Emilio Bouza.

 

Please use the link to join the meeting

Join Meeting

2020 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. 2020 was a challenging year due to COVID-19, but check out the report to see what the Study Group was able to accomplish or plan for the future.

New ESGCD Executive Committee elected

Here is the new ESGCP Executive Committee:

  • Chair: Fidelma Fitzpatrick, Ireland
  • Secretary: Marcela Krutova, Czech Republic
  • Treasurer: Elena Reigadas, Spain
  • Education Officer: Kerrie Davies, United Kingdom
  • Science Officer: Benoit Guery, Switzerland

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

You can find the full election report here

ESGCD Study Group Poster 2020

April 23, 2020

Here we present the ESGCD Study Group poster for ECCMID 2020. Inside you can see what publications and activities ESGCD has been focusing on and what they have planned coming up soon. Click here to learn more!

ESGCD Newsletter, January 2020

January 20, 2020

The new ESGCD newsletter has just been finished. Take a look at all of the activities that have been done this year and what is ahead along with ECCMID 2020. Read the full article here

ESCMID Clinical Guidelines

Still difficult; clinical practice guidelines for Clostridioides difficile infection

 

ESCMID guidelines concerning CDI and CDAD

 

C. difficile culture collection

The ESGCD culture collection of C. difficile is based in the Anaerobe Reference Laboratory at the University Hospital of Wales, Cardiff, UK. Cultures are kept on beads at -80 degrees Celsius. Colleagues wishing to deposit isolates should apply to Dr. J.S. Brazier via email.



The collection is meant for collaborative study purposes and to act as a bank of European isolates representing those strains causing infections across Europe.